With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Global shares mostly rose Wednesday, as markets continued to watch President Donald Trump’s latest tariff escalation.

Chinese authorities are considering a plan to assist China Vanke in covering a funding shortfall of about 50 billion yuan ($6 ...